Current Drug Treatment Strategies for Atrial Fibrillation and TASK-1 Inhibition as an Emerging Novel Therapy Option

• Hauptverfasser: Manuel Kraft (Verfasst von), Antonius Büscher (Verfasst von), Felix Wiedmann (Verfasst von), Yannick L'hoste (Verfasst von), Walter E. Haefeli (Verfasst von), Norbert Frey (Verfasst von), Hugo A. Katus (Verfasst von), Constanze Schmidt (Verfasst von)
• Format: Buch
• Veröffentlicht: Frontiers Media S.A., 2021-03-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Atrial fibrillation (AF) is the most common sustained arrhythmia with a prevalence of up to 4% and an upwards trend due to demographic changes. It is associated with an increase in mortality and stroke incidences. While stroke risk can be significantly reduced through anticoagulant therapy, adequate...